Kampen, W.U.
Boddenberg-Pätzold, B.
Fischer, M.
Gabriel, M.
Klett, R.
Konijnenberg, M.
Kresnik, E.
Lellouche, H.
Paycha, F.
Terslev, L.
Turkmen, C.
van der Zant, F.
Antunovic, L.
Panagiotidis, E.
Gnanasegaran, G.
Kuwert, T.
Van den Wyngaert, T.
,
Funding for this research was provided by:
Friedrich-Alexander-Universität Erlangen-Nürnberg
Article History
Received: 23 June 2021
Accepted: 23 August 2021
First Online: 20 October 2021
Change Date: 25 February 2022
Change Type: Update
Change Details: The original version of this paper was updated to add the missing compact agreement Open Access funding note.
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Author W.U. Kampen has received travel grants and speakers fee from Curium Germany in the past, lastly in 2016.Author M. Fischer is an external medical advisor regarding pharmacovigilance of Curium Germany GmbH, which does not mean any potential conflict of interest regarding this publication.Author L. Terslev has received speakers fee from AbbVie, Janssen, Roche, Novartis, Pfizer, MSD, BMS, and GE.Authors W. U. Kampen, F. Paycha, L. Antunovic, M. Panagiotidis, G. Gnanasegaran, T. Kuwert, and T. v.d. Wyngaert are or were members of the EANM Bone & Joint committee, M. Konijnenberg is a member of the EANM Dosimetry Committee, and G. Gnanasegaran is now a member of the Oncology & Theranostics committee.Authors B. Boddenberg-Pätzold, M. Gabriel, R. Klett, M. Konijnenberg, E. Kresnik, H. Lellouche, F. Paycha, C. Turkmen, F. van der Zant, L. Antunovic, M. Panagiotidis, G. Gnanasegaran, T. Kuwert, and T. v.d. Wyngaert declare that they have no conflict of interest (except those being members of the abovementioned committees).